Other OTC - Delayed Quote • USD
Vapotherm, Inc. (VAPO)
At close: April 18 at 3:49 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
68,669.0000
68,669.0000
66,801.0000
113,292.0000
125,733.0000
Cost of Revenue
40,386.0000
40,386.0000
49,558.0000
60,104.0000
62,687.0000
Gross Profit
28,283.0000
28,283.0000
17,243.0000
53,188.0000
63,046.0000
Operating Expense
66,025.0000
66,025.0000
94,689.0000
109,925.0000
106,060.0000
Operating Income
-37,742.0000
-37,742.0000
-77,446.0000
-56,737.0000
-43,014.0000
Net Non Operating Interest Income Expense
-18,655.0000
-18,655.0000
-11,504.0000
-2,504.0000
-4,454.0000
Other Income Expense
-1,670.0000
-1,670.0000
-24,298.0000
-635.0000
-4,034.0000
Pretax Income
-58,067.0000
-58,067.0000
-113,248.0000
-59,876.0000
-51,502.0000
Tax Provision
126.0000
126.0000
11.0000
-76.0000
--
Net Income Common Stockholders
-58,193.0000
-58,193.0000
-113,259.0000
-59,800.0000
-51,502.0000
Diluted NI Available to Com Stockholders
-58,193.0000
-58,193.0000
-113,259.0000
-59,800.0000
-51,502.0000
Basic EPS
-14.33
-9.64
-33.89
-18.48
-17.28
Diluted EPS
-14.33
-9.64
-33.89
-18.48
-17.28
Basic Average Shares
5,299.1430
6,037.4680
3,341.6170
3,242.1210
2,977.3050
Diluted Average Shares
5,299.1430
6,037.4680
3,341.6170
3,242.1210
2,977.3050
Total Operating Income as Reported
-39,080.0000
-39,080.0000
-100,391.0000
-57,165.0000
-43,014.0000
Total Expenses
106,411.0000
106,411.0000
144,247.0000
170,029.0000
168,747.0000
Net Income from Continuing & Discontinued Operation
-58,193.0000
-58,193.0000
-113,259.0000
-59,800.0000
-51,502.0000
Normalized Income
-56,526.3400
-56,526.3400
-88,961.0000
-59,147.8288
-47,468.0000
Interest Income
78.0000
78.0000
139.0000
91.0000
257.0000
Interest Expense
18,733.0000
18,733.0000
11,643.0000
2,595.0000
4,711.0000
Net Interest Income
-18,655.0000
-18,655.0000
-11,504.0000
-2,504.0000
-4,454.0000
EBIT
-39,334.0000
-39,334.0000
-101,605.0000
-57,281.0000
-46,791.0000
EBITDA
-34,357.0000
-34,357.0000
-96,425.0000
-51,633.0000
-42,022.0000
Reconciled Cost of Revenue
40,386.0000
40,386.0000
49,558.0000
60,104.0000
62,687.0000
Reconciled Depreciation
4,977.0000
4,977.0000
5,180.0000
5,648.0000
4,769.0000
Net Income from Continuing Operation Net Minority Interest
-58,193.0000
-58,193.0000
-113,259.0000
-59,800.0000
-51,502.0000
Total Unusual Items Excluding Goodwill
-1,670.0000
-1,670.0000
-24,298.0000
-653.0000
-4,034.0000
Total Unusual Items
-1,670.0000
-1,670.0000
-24,298.0000
-653.0000
-4,034.0000
Normalized EBITDA
-32,687.0000
-32,687.0000
-72,127.0000
-50,980.0000
-37,988.0000
Tax Rate for Calcs
0.0000
0.0000
--
0.0000
--
Tax Effect of Unusual Items
-3.3400
-3.3400
--
-0.8288
--
12/31/2020 - 11/14/2018
Yahoo Finance Plus Essential access required. Unlock Access
Related Tickers
VERO Venus Concept Inc.
0.8400
+8.43%
SIBN SI-BONE, Inc.
15.30
+0.46%
XTNT Xtant Medical Holdings, Inc.
0.8372
+6.73%
SONX Sonendo, Inc.
0.0884
-3.88%
LUNG Pulmonx Corporation
7.50
+0.94%
NPCE NeuroPace, Inc.
14.00
+1.82%
TNON Tenon Medical, Inc.
0.7500
-2.60%
THMO ThermoGenesis Holdings, Inc.
0.6500
+4.18%
CVRX CVRx, Inc.
15.26
-2.86%
BVS Bioventus Inc.
4.5500
-3.19%